Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 17;14:5029–5041. doi: 10.2147/DDDT.S266470

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Chiu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Recurrent HCCs in an 83-year-old man with HBV cirrhosis of liver and HCC in segment seven received hepatectomy before. (A) The arterial phase of MDCT before TACE showed two recurrent HCCs (arrows) in the both lobes of liver. (B) During TACE, the DSA of right hepatic artery (black arrow) demonstrated three hypervascular tumors (arrows) in both lobes of the liver (one was not in the same cut of MDCT). (C) The following CBCT-HA of right hepatic artery indicated the recurrent HCC in segment seven (dotted line) was only enhanced in its anterior portion (arrow); the nonenhanced portion may be supplied by other vessels. (D) The DSA of RIPA (black arrow) showed a hypervascular tumor (arrow) near liver dome. (E) The following CBCT-A of RIPA confirmed the posterior portion of recurrent HCC in segment seven (dotted line) was supplied by RIPA, and chemoembolization with drug-eluting beads was then performed. (F) One month after TACE, the MDCT indicated complete response (arrows) of the recurrent HCCs.